Loading...
Diabetic cardiomyopathy
Matthew M.Y. Lee John McMurray Ana Lorenzo-Almorós Søren L. Kristensen Naveed Sattar Pardeep Jhund Mark C. Petrie
Matthew M.Y. Lee
John McMurray
Ana Lorenzo-Almorós
Søren L. Kristensen
Naveed Sattar
Pardeep Jhund
Mark C. Petrie
Abstract
Heart failure in patients with diabetes has been recognised since 1876. The cardiovascular harm of thiazolidinediones shone the 21st century spotlight on the interaction between these two conditions. Recent clinical trials reporting cardiovascular benefit of drugs used to treat diabetes have sparked even more interest. The phrase ‘diabetic cardiomyopathy’ entered the literature in 1972.8 Over subsequent years, there has been a steady increase in the use of the term. There is a debate about the existence of a distinct diabetic cardiomyopathy. Some investigators have used the term ‘diabetic cardiomyopathy’ to describe all effects of diabetes on the heart and cardiovascular system but this is at odds with definitions offered to date.
Keywords
Date
2019
Type
Journal article
Journal
Heart
Book
Volume
105
Issue
4
Page Range
337-345
Article Number
ACU Department
Collections
Relation URI
Source URL
Event URL
Open Access Status
License
File Access
Controlled